These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5510729)

  • 21. Pemphigus herpetiformis associated with prostate cancer.
    Marzano AV; Tourlaki A; Cozzani E; Gianotti R; Caputo R
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):696-8. PubMed ID: 17447995
    [No Abstract]   [Full Text] [Related]  

  • 22. [Duhring-Brocq disease with antibodies and methotrexate. Current clinical and biological results].
    Beurey J; Weber M; Fournier A; Siboul M; Guibert M
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):431-2. PubMed ID: 5004841
    [No Abstract]   [Full Text] [Related]  

  • 23. [Laryngeal pemphigus].
    Charpy N; Franck N; Lecanu JB; Pelisse M
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(5):345-8. PubMed ID: 17425010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pemphigus herpetiformis with minocycline and nicotinamide.
    Wu C; Zuo Y; Jin H; Chen J; Li L
    Chin Med J (Engl); 2014; 127(19):3514. PubMed ID: 25269925
    [No Abstract]   [Full Text] [Related]  

  • 25. Herpetiform pemphigus foliaceus responsive to dapsone.
    Connor B
    Br J Dermatol; 1972 Jan; 86(1):99-101. PubMed ID: 5060427
    [No Abstract]   [Full Text] [Related]  

  • 26. [Herpetic superinfection of pemphigus: 6 cases].
    Zouhair K; el Ouazzani T; Azzouzi S; Sqalli S; Lakhdar H
    Ann Dermatol Venereol; 1999 Oct; 126(10):699-702. PubMed ID: 10604008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of psoriasis vulgaris and bullous disorders.
    Aytekin S; Inalöz HS; Harman M; Akdeniz S; Deveci E; Inalöz SS
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):185-7. PubMed ID: 10343958
    [No Abstract]   [Full Text] [Related]  

  • 28. [Various cases of pemphigus (treatment with corticosteroids + immunosuppressive agents)].
    Rocha GL; Miranda O; Ciuffo D; Mesquita A; Olivi WR; Balassiano E; Szrman WH
    Hospital (Rio J); 1969 Dec; 76(6):2099-106. PubMed ID: 5309259
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pemphigus non acantholyticus proprius].
    Sheklakov ND
    Vestn Dermatol Venerol; 1966 Oct; 40(10):12-8. PubMed ID: 5997909
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of pemphigus and parapemphigus].
    Nebe H; Sönnichsen N
    Dermatol Monatsschr; 1972 May; 158(5):368-77. PubMed ID: 5043288
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combined immunosuppressive therapy in patients with pemphigus vulgaris and its side effects].
    Vojácková N; Hejcmanová I; Schmiedbergerová R; Hercogová J
    Cas Lek Cesk; 2005; 144(12):833-5. PubMed ID: 16389757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of synthetic ACTH in the therapy of dermatologic diseases].
    Schuppli R
    Dermatologica; 1969; 139(4):243-53. PubMed ID: 4392894
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the differential diagnosis between dermatitis herpetiformis Duhring and bullous pemphigoid].
    Kresbach H; Hartwagner A
    Z Haut Geschlechtskr; 1967 Mar; 43(5):165-76. PubMed ID: 5586062
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pemphigus herpetiformis: a clinical variant of pemphigus vulgaris].
    Bauer R; Orfanos CE
    Hautarzt; 1980 Oct; 31(10):540-4. PubMed ID: 7005184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nosological specificity of dermatosis pustulosa subcornealis in the group of bullous diseases].
    KOZMINSKA A
    Przegl Dermatol; 1962; 49(Suppl)():85-8. PubMed ID: 14035342
    [No Abstract]   [Full Text] [Related]  

  • 36. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
    Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
    Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with prophylactic medical care of vesiculobullous diseases (author's transl)].
    Rozsívalová V
    Cesk Dermatol; 1978 Jan; 53(1):40-4. PubMed ID: 350429
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Arin MJ; Engert A; Krieg T; Hunzelmann N
    Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and treatment of pemphigus in Iran.
    Chams-Davatchi C
    Dermatol Clin; 2011 Oct; 29(4):681-3. PubMed ID: 21925018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicular and bullous disorders: pemphigus.
    Baroni A; Lanza A; Cirillo N; Brunetti G; Ruocco E; Ruocco V
    Dermatol Clin; 2007 Oct; 25(4):597-603, ix. PubMed ID: 17903618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.